Back
DexCom 10K Form
Sell
37
DXCM
DexCom
Last Price:
$70.67
Seasonality Move:
9.96%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-25 | 10Q | DXCM/DexCom Quarterly |
| 2023-10-26 | 10Q | DXCM/DexCom Quarterly |
| 2023-07-27 | 10Q | DXCM/DexCom Quarterly |
| 2023-04-27 | 10Q | DXCM/DexCom Quarterly |
| 2022-10-27 | 10Q | DXCM/DexCom Quarterly |
| 2022-07-28 | 10Q | DXCM/DexCom Quarterly |
Receive DXCM News And Ratings
See the #1 stock for the next 7 days that we like better than DXCM
DXCM Financial Statistics
Sales & Book Value
| Annual Sales: | $4B |
|---|---|
| Cash Flow: | $176.8M |
| Price / Cash Flow: | 46.25 |
| Annual Sales: | $5.38 |
| Price / Book: | 13.14 |
Profitability
| EPS (TTM): | 1.43000 |
|---|---|
| Net Income (TTM): | $576.2M |
| Gross Margin: | $2.4B |
| Return on Equity: | 26.6% |
| Return on Assets: | 8.9% |
DexCom Earnings Forecast
Key DexCom Financial Ratios
-
The Gross Profit Margin over the past 20 years for DXCM is 60.46%.
-
The Selling, General & Administrative Expenses for DXCM have been equal to 31.88% of Gross Profit Margin.
-
The Research & Development expenses have been 13.70% of Revenue.
-
The Interest Expense is 3.30% of Operating Income.
-
The Net Earning history of DXCM is 14.29% of Total Revenues.
-
Per Share Earnings over the last 25 years have been positive in 13 years.
DexCom Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | DXCM |
| CUSIP: | 252131 |
| Website: | dexcom.com |
Debt
| Debt-to-Equity Ratio: | 1.16 |
|---|---|
| Current Ratio: | 1.47 |
| Quick Ratio: | 1.23 |
Price-to-Earnings
| Trailing P/E Ratio: | 49.78 |
|---|---|
| Forward P/E Ratio: | 28.63 |